ASPIRIN

Product NDC: 41226-481
11-digit product format: 412260481
Labeler code: 41226
Product ID: 41226-481_3f2389df-b5d8-1dfd-e063-6294a90a6e99
Type: HUMAN OTC DRUG
Nonproprietary name: ASPIRIN
Dosage form: TABLET, COATED
Route: ORAL
Labeler: Kroger Company
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2021-04-10
Substance: ASPIRIN
Active strength: 81 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 40 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41226-481-12	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41226-481-50	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41226-481-31	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41226-481-20	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41226-481-12	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41226-481-50	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41226-481-31	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41226-481-20	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41226-481-12	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41226-481-50	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41226-481-31	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41226-481-20	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41226-481-12	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41226-481-50	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41226-481-31	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41226-481-20	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41226-481-12	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41226-481-50	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41226-481-31	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41226-481-20	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41226-481-31	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41226-481-12	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41226-481-20	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41226-481-50	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41226-481-31	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41226-481-12	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41226-481-20	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41226-481-50	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41226-481-31	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41226-481-12	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41226-481-20	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41226-481-50	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: ASPIRIN
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ASPIRIN	81 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308416	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
bbee8ee4-e09d-3ba6-e053-2a95a90af647	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
41226-481-12	2025-09-23	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-20	2025-09-23	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-31	2025-09-23	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-50	2025-09-23	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-12	2025-01-30	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-20	2025-01-30	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-31	2025-01-30	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-50	2025-01-30	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
41226-481-12	ASPIRIN	1 in 1 CARTON	TABLET, COATED	1	4
41226-481-12	ASPIRIN	120 in 1 BOTTLE	TABLET, COATED	120	4
41226-481-20	ASPIRIN	200 in 1 BOTTLE	TABLET, COATED	200	4
41226-481-20	ASPIRIN	1 in 1 CARTON	TABLET, COATED	1	4
41226-481-31	ASPIRIN	300 in 1 BOTTLE	TABLET, COATED	300	4
41226-481-50	ASPIRIN	500 in 1 BOTTLE	TABLET, COATED	500	4
41226-481-50	ASPIRIN	1 in 1 BOTTLE	TABLET, COATED	1	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
41226-481	ASPIRIN TABLET, COATED [KROGER COMPANY]	3	Current NDC, Legacy NDC, 7 package rows	20210616_bbee8ee4-e09d-3ba6-e053-2a95a90af647.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 24 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Menstrual Relief Maximum Strength	ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE	United Natural Foods, Inc. dba UNFI	807598ef-9f03-48df-b076-3ee95ef4b06c	2026-01-05	Warnings	Exact identifier application number: M013
Pain Relief Extra Strength, Non-Aspirin	ACETAMINOPHEN	CHAIN DRUG MARKETING ASSOCIATION INC	1fb5e871-45fd-46fe-bf73-5192f8316e8e	2026-01-02	Warnings	Exact identifier application number: M013
Pain Reliever Extra Strength	ACETAMINOPHEN	Valu Merchandisers Company	0005aafa-08f8-4990-a54d-cc097195708f	2026-01-02	Warnings	Exact identifier application number: M013
Extra Strength Pain Reliever	ACETAMINOPHEN	Walmart Inc.	152bb455-da5b-ae13-e063-6394a90acab0	2026-01-01	Warnings	Exact identifier application number: M013
Dr. Cocoa for Children Pain and Fever	ACETAMINOPHEN	Infirst Healthcare Inc.	486ea294-6d18-a907-e063-6294a90ad284	2026-01-01	Warnings	Exact identifier application number: M013
ED APAP	ACETAMINOPHEN	EDWARDS PHARMACEUTICALS, INC.	f76d5fff-ebea-40f9-aad3-4064a0c863f0	2025-12-31	Warnings	Exact identifier application number: M013
EXTRA STRENGTH PAIN RELIEF	ACETAMINOPHEN	GERI-CARE PHARMACEUTICAL CORP	99ec63ef-aa28-c2fb-e053-2a95a90a9f6d	2025-12-31	Warnings	Exact identifier application number: M013
Puregen Labs Acetaminophen	ACETAMINOPHEN	Advanced Rx LLC	474580af-f6b0-e440-e063-6394a90aaada	2025-12-31	Warnings	Exact identifier application number: M013
Liquid Acetaminophen	ACETAMINOPHEN	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	a7dbd4c0-53eb-4368-917b-1432c09ce6b4	2025-12-31	Warnings	Exact identifier application number: M013
Llorens Care Children Acetaminophen	ACETAMINOPHEN	Llorens Pharmaceutical International Division, Inc.	2a46d7d2-293b-5024-e063-6294a90a31aa	2025-12-31	Warnings	Exact identifier application number: M013
Pain Reliever	ACETAMINOPHEN CAPSULES 500MG (MINIS-RED OPAQUE)	Walgreens	3a801457-c5d0-b134-e063-6294a90ac5cb	2025-12-31	Warnings	Exact identifier application number: M013
Daytime and Nighttime Severe Cold and Flu combo pack	ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE	Genexa Inc.	190c7eaf-dcd4-d314-e063-6294a90a6f33	2025-12-30	Warnings	Exact identifier application number: M013
BioElectro Extra Strength Headache Relief	ACETAMINOPHEN, ASPIRIN, AND CAFFEINE	Genomma Lab USA	683a0fba-921c-48e7-a391-180c04f0d1c4	2025-12-30	Warnings	Exact identifier application number: M013
Pain Relief PM	ACETAMINOPHEN, DIPHENHYDRAMINE	Pioneer Life Sciences, LLC	0181af13-da32-4431-be39-c31fdfac9202	2025-12-29	Warnings	Exact identifier application number: M013
Gemma Cut the Cramp	ASPIRIN, CAFFEINE	Rally Labs LLC	16c9a296-077a-8e12-e063-6294a90a1b8b	2025-12-29	Warnings	Exact identifier application number: M013
Blowfish	ASPIRIN, CAFFEINE	Rally Labs LLC	0d3798bc-04ef-584e-821b-7aa76036b7d1	2025-12-29	Warnings	Exact identifier application number: M013
Pain Relief PM	ACETAMINOPHEN, DIPHENHYDRAMINE	Pioneer Life Sciences, LLC	ad29a37f-39a2-5c84-e053-2995a90a2f39	2025-12-29	Warnings	Exact identifier application number: M013
Tension Headache Relief	ACETAMINOPHEN, CAFFEINE	Pioneer Life Sciences, LLC	ac9efd62-8fee-b777-e053-2995a90a3783	2025-12-29	Warnings	Exact identifier application number: M013
Childrens Pain Relief and Fever Reducer Oral Suspension Cherry	ACETAMINOPHEN	Puro Pharma Inc.	a2afaee7-19f3-4a42-a5b8-1d0ef3ecf009	2025-12-27	Warnings	Exact identifier application number: M013
Cystex PM	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	Clarion Brands, LLC	9668a2ca-729e-4172-80b5-33e6c5175ba4	2025-12-27	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	bbee8ee4-e09d-3ba6-e053-2a95a90af647	4
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	bbee8ee4-e09d-3ba6-e053-2a95a90af647	4
308416	ASA 81 MG Delayed Release Oral Tablet	SY	bbee8ee4-e09d-3ba6-e053-2a95a90af647	4
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	bbee8ee4-e09d-3ba6-e053-2a95a90af647	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
41226-481-12	41226048112	1 BOTTLE in 1 CARTON (41226-481-12) / 120 TABLET, COATED in 1 BOTTLE	1 bottle	2021-06-12	0000-00-00	No	No	Current
41226-481-20	41226048120	1 BOTTLE in 1 CARTON (41226-481-20) / 200 TABLET, COATED in 1 BOTTLE	1 bottle	2021-06-12	0000-00-00	No	No	Current
41226-481-31	41226048131	300 TABLET, COATED in 1 BOTTLE (41226-481-31)		2021-06-12	0000-00-00	No	No	Current
41226-481-50	41226048150	1 BOTTLE in 1 BOTTLE (41226-481-50) / 500 TABLET, COATED in 1 BOTTLE	1 bottle	2021-04-10	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets	Kroger Company \| Time Cap Laboratories, Inc.	2025-09-19	HUMAN OTC DRUG LABEL	4